The effect of growth hormone on the metabolome of follicular fluid in patients with diminished ovarian reserve
Open Access
- 27 February 2023
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 21 (1) , 1-11
Abstract
Background: Increasing evidence supports that the co-treatment with growth hormone (GH) enhances ovarian response and oocyte quality during controlled ovarian stimulation (COS) in patients with diminished ovarian reserve (DOR). The composition of follicular fluid (FF) plays an essential role in oocyte development and mirrors the communication occurring between the oocyte and follicular microenvironment. However, the effect of GH on the FF metabolome remains unclear. Methods: This prospective observational study recruited DOR patients undergoing in vitro fertilization (IVF) cycles with minimal stimulation protocol for COS. Each patient receiving GH co-treatment was matched to a patient without GH co-treatment by propensity score matching. The FF was collected after isolating oocytes and assayed by gas chromatograph-mass spectrometry (GC-MS) metabolomics. The Pearson correlation was performed to evaluate the relationship between the number of oocytes retrieved and the levels of differential metabolites. The KEGG database was used to map differential metabolites onto various metabolic pathways. Results: One hundred thirty-four FF metabolites were identified by GC-MS metabolomics. Twenty-four metabolites, including glutathione, itaconic acid and S-adenosylmethionin (SAM) showed significant differences between the GH and control groups (p-value < 0.05 and q-value < 0.1). In addition, the number of oocytes retrieved was significantly higher in the GH group compared to the control group (3 vs 2, p = 0.04) and correlated with the levels of five differential metabolites. Among them, the levels of antioxidant metabolite itaconic acid were upregulated by GH administration, while SAM levels were downregulated. Conclusions: The co-treatment with GH during COS may improve oocyte development by altering FF metabolite profiles in DOR patients. However, given the downregulation of SAM, a regulator of genomic imprinting, the potential risk of imprinting disturbances should not be neglected.Keywords
Funding Information
- National Natural Science Foundation of China (82001554, 82101710, 81871185)
- Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University
- Medical Research Foundation of Sichuan Medical Association (S18071)
- Natural Science Foundation of Chongqing Municipality (cstc2021jcyj-msxmX0097, cstc2021jcyj-msxmX0213)
- Chongqing Municipal Education Commission (KJZD-K202100407)
This publication has 61 references indexed in Scilit:
- Age- and sex-dependent DNA hypomethylation controlled by growth hormone in mouse liverMechanisms of Ageing and Development, 2013
- Intracellular Ca2+ and antioxidant values induced positive effect on fertilisation ratio and oocyte quality of granulosa cells in patients undergoing in vitro fertilisationReproduction, Fertility and Development, 2012
- An investigation into the relationship between the metabolic profile of follicular fluid, oocyte developmental potential, and implantation outcomeFertility and Sterility, 2012
- Growth hormone reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluationEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Analytical platform for metabolome analysis of microbial cells using methyl chloroformate derivatization followed by gas chromatography–mass spectrometryNature Protocols, 2010
- Follicular fluid content and oocyte quality: from single biochemical markers to metabolomicsReproductive Biology and Endocrinology, 2009
- Regulation of glutathione synthesisMolecular Aspects of Medicine, 2009
- Growth hormone and its receptor in human ovaries from fetuses and adultsFertility and Sterility, 2008
- Growth Hormone Alters Components of the Glutathione Metabolic Pathway in Ames Dwarf MiceaAnnals of the New York Academy of Sciences, 2004